Peptide Drug Hunting Consortium
A nonprofit built to hunt better medicines
A scientific and educational 501(c)(3), founded in 2024, supporting the development of innovative peptide therapeutic modalities.
Challenges and opportunities
Peptides sit between small molecules and antibodies
They open historically undruggable targets, if we solve delivery, permeability, and chemistry at scale.
Target space
The druggable proteome, explorable
Mapped regions of intracellular and extracellular targets, waiting for the right peptide modality to light them up.
Strategic partnering
Partnerships that organize the space
Academia, biotech, pharma, and contract R&D connect across disciplines so the field scales together.
Proteome program
A knowledge layer that compounds
Data capture, design rules, and ADME delivery intelligence feed one translational logic for every program.
The network
One world, many disciplines, connected
Investors, academia, biotech, pharma, contract R&D, and service providers, wired into a single consortium.
Breakthrough therapeutics
From hunt to breakthrough medicine
Shared knowledge and mentorship turn bold ideas into therapies that improve patient outcomes.
A non-profit community built to accelerate peptide translation through entrepreneurial science.
peptidedrughunting.org01 / The hunt
Six technologies, one loop
Our mission is to support peptide drug hunting through shared knowledge, mentorship, and sponsorship of innovative science and technology initiatives that improve prospective outcomes.
02 / The consortium
Shared knowledge, mentorship, and sponsorship
The solution
A worldwide consortium of entrepreneurs with multidisciplinary expertise across the entire peptide drug hunting enterprise.
Collective genius
Accomplished scientists from every field of peptide science and technology, working together on the field's biggest challenges.
The vision
Pioneering innovative and affordable science can unlock peptide therapeutics for unmet medical needs worldwide.
03 / The network
One network spanning peptide drug hunting
AcademiaDiscovery science and the training of new hunters
BiotechEarly programs, platforms, and first-in-class risk
PharmaDevelopment scale, regulatory depth, global reach
InvestorsCapital that carries science into the clinic
Service providersTools, analytics, and material supply
Contract R&DSynthesis, assay work, and study execution